{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:07:40Z","timestamp":1791338860292,"version":"4.3.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["11889"],"award-info":[{"award-number":["11889"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["11889"],"award-info":[{"award-number":["11889"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>An emerging group of patients lives longer with advanced cancer while receiving systemic treatment. This study aimed to investigate psychosocial aspects of living longer with advanced cancer, and experiences with psychosocial care, from the perspectives of patients, partners, and health care professionals (HCPs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From May to December 2020, participants were purposively selected. In-depth, semi-structured interviews were conducted by video or phone call, containing open questions regarding psychosocial aspects and psychosocial care in oncology. The data was analysed following thematic analysis, leading to overarching psychosocial themes and indications for optimal organisation of psycho-oncological care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen patients, seven partners and eleven HCPs were interviewed. The main psychosocial aspects were increasing loss in several life domains, complexity of making life choices, ongoing uncertainty, and fluctuating fear and hope. Partners were affected by their loved ones\u2019 condition and reported to put themselves second for longer periods of time, while sometimes missing adequate support. HCPs were challenged by addressing the altering psychosocial needs of patients, and tools to identify those in need for psychosocial support are currently lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Living longer with advanced cancer presents unique challenges for patients and their partners, as well as for HCPs in delivering optimal psychosocial care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications for Cancer Survivors<\/jats:title>\n                    <jats:p>Identifying and addressing patients\u2019 psychosocial needs from an early stage on, appointing a central hospital-based contact person, limiting the waiting time between scans and consultations, and addressing the partners\u2019 wellbeing are suggestions to organise optimal psychosocial support in advanced cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11764-024-01698-w","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T04:31:44Z","timestamp":1730176304000},"page":"940-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment"],"prefix":"10.1007","volume":"20","author":[{"given":"Evie E. M.","family":"Kolsteren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Deuning-Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith B.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winette T. A.","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Kwakkenbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A. E.","family":"Custers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"1698_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.breast.2016.10.005","volume":"31","author":"M Sundquist","year":"2017","unstructured":"Sundquist M, Brudin L, Tejler G. Improved survival in metastatic breast cancer 1985\u20132016. Breast. 2017;31:46\u201350.","journal-title":"Breast"},{"issue":"7","key":"1698_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1916623","volume":"383","author":"N Howlader","year":"2020","unstructured":"Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383(7):640\u20139.","journal-title":"N Engl J Med"},{"issue":"9919","key":"1698_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","volume":"383","author":"AM Eggermont","year":"2014","unstructured":"Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet. 2014;383(9919):816\u201327.","journal-title":"Lancet"},{"issue":"10","key":"1698_CR4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2312117","volume":"390","author":"T Powles","year":"2024","unstructured":"Powles T, Valderrama BP, Gupta S, Bedke J, Kikuchi E, Hoffman-Censits J, et al. Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer. N Engl J Med. 2024;390(10):875\u201388.","journal-title":"N Engl J Med"},{"issue":"23","key":"1698_CR5","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1056\/NEJMra2034861","volume":"384","author":"BD Curti","year":"2021","unstructured":"Curti BD, Faries MB. Recent advances in the treatment of melanoma. N Engl J Med. 2021;384(23):2229\u201340.","journal-title":"N Engl J Med"},{"issue":"6","key":"1698_CR6","doi-asserted-by":"publisher","first-page":"100320","DOI":"10.1016\/j.esmoop.2021.100320","volume":"6","author":"MG Franken","year":"2021","unstructured":"Franken MG, Leeneman B, Aarts MJB, van Akkooi ACJ, van den Berkmortel F, Boers-Sonderen MJ, et al. Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs. ESMO Open. 2021;6(6):100320.","journal-title":"ESMO Open"},{"issue":"12","key":"1698_CR7","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.3390\/ijms23126748","volume":"23","author":"A Michelotti","year":"2022","unstructured":"Michelotti A, de Scordilli M, Bertoli E, De Carlo E, Del Conte A, Bearz A. NSCLC as the paradigm of precision medicine at its finest: the rise of new druggable molecular targets for advanced disease. Int J Mol Sci. 2022;23(12):6748.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1698_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.critrevonc.2015.07.009","volume":"96","author":"JS Thomas","year":"2015","unstructured":"Thomas JS, Kabbinavar F. Metastatic clear cell renal cell carcinoma: a review of current therapies and novel immunotherapies. Crit Rev Oncol Hematol. 2015;96(3):527\u201333.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"1698_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/bjs.10809","volume":"105","author":"WTA van der Graaf","year":"2018","unstructured":"van der Graaf WTA, Tielen R, Bonenkamp JJ, Lemmens V, Verhoeven RHA, de Wilt JHW. Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era. Br J Surg. 2018;105(8):1020\u20137.","journal-title":"Br J Surg"},{"issue":"1","key":"1698_CR10","doi-asserted-by":"publisher","first-page":"e040808","DOI":"10.1136\/bmjopen-2020-040808","volume":"11","author":"R White","year":"2021","unstructured":"White R, Stanley F, Than J, Macnair A, Pethick J, Fallica G, et al. Treatable but not curable cancer in England: a retrospective cohort study using cancer registry data and linked data sets. BMJ Open. 2021;11(1):e040808.","journal-title":"BMJ Open"},{"key":"1698_CR11","doi-asserted-by":"publisher","first-page":"e076625","DOI":"10.1136\/bmj-2023-076625","volume":"384","author":"ECT Geijteman","year":"2024","unstructured":"Geijteman ECT, Kuip EJM, Oskam J, Lees D, Bruera E. Illness trajectories of incurable solid cancers. Bmj. 2024;384:e076625.","journal-title":"Bmj"},{"issue":"4","key":"1698_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11764-019-00770-0","volume":"13","author":"J Lai-Kwon","year":"2019","unstructured":"Lai-Kwon J, Khoo C, Lo S, Milne D, Mohamed M, Raleigh J, et al. The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors. J Cancer Surviv. 2019;13(4):503\u201311.","journal-title":"J Cancer Surviv"},{"issue":"5","key":"1698_CR13","first-page":"1845","volume":"27","author":"D Levy","year":"2019","unstructured":"Levy D, Dhillon HM, Lomax A, Marthick M, McNeil C, Kao S, Lacey J. Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy. Support Care Cancer. 2019;27(5):1845\u201352.","journal-title":"Support Care Cancer"},{"issue":"8","key":"1698_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1200\/OP.20.00183","volume":"16","author":"L Spoozak","year":"2020","unstructured":"Spoozak L, Wulff-Burchfield E, Brooks JV. Rallying cry from the place in between. JCO Oncol Pract. 2020;16(8):451\u20132.","journal-title":"JCO Oncol Pract"},{"issue":"14","key":"1698_CR15","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1056\/NEJMp1901103","volume":"380","author":"T Langbaum","year":"2019","unstructured":"Langbaum T, Smith TJ. Time to study metastatic-cancer survivorship. New Engl J Med. 2019;380(14):1300.","journal-title":"New Engl J Med"},{"issue":"4","key":"1698_CR16","first-page":"222","volume":"32","author":"LC Zwanenburg","year":"2024","unstructured":"Zwanenburg LC, van der Lee ML, Koldenhof JJ, Suijkerbuijk KPM, Schellekens MPJ. What patients with advanced cancer experience as helpful in navigating their life with a long-term response: a qualitative study. Support Care Cancer. 2024;32(4):222.","journal-title":"Support Care Cancer"},{"issue":"3","key":"1698_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/pon.6093","volume":"32","author":"T Langmuir","year":"2023","unstructured":"Langmuir T, Chu A, Sehabi G, Giguere L, Lamarche J, Boudjatat W, Lebel S. A new landscape in illness uncertainty: a systematic review and thematic synthesis of the experience of uncertainty in patients with advanced cancer receiving immunotherapy or targeted therapy. Psychooncology. 2023;32(3):356\u201367.","journal-title":"Psychooncology"},{"issue":"4","key":"1698_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/bmjspcare-2012-000381","volume":"5","author":"EA Lobb","year":"2015","unstructured":"Lobb EA, Lacey J, Kearsley J, Liauw W, White L, Hosie A. Living with advanced cancer and an uncertain disease trajectory: an emerging patient population in palliative care? BMJ Support Palliat Care. 2015;5(4):352\u20137.","journal-title":"BMJ Support Palliat Care"},{"key":"1698_CR19","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s11764-022-01306-9","volume":"18","author":"LC Zwanenburg","year":"2022","unstructured":"Zwanenburg LC, Suijkerbuijk KPM, van Dongen SI, Koldenhof JJ, van Roozendaal AS, van der Lee ML, Schellekens MPJ. Living in the twilight zone: a qualitative study on the experiences of patients with advanced cancer obtaining long-term response to immunotherapy or targeted therapy. J Cancer Surviv. 2022;18:750\u201360.","journal-title":"J Cancer Surviv"},{"issue":"4","key":"1698_CR20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/jnci\/djad267","volume":"116","author":"J Mathews","year":"2023","unstructured":"Mathews J, Merchant S, Galica J, Palmer MJ, O\u2019Donnell J, Koven R, et al. Measuring prognostic awareness in patients with advanced cancer: a scoping review and interpretive synthesis of the impact of hope. J Natl Cancer Inst. 2023;116(4):506\u201317.","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"1698_CR21","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.3390\/cancers14163889","volume":"14","author":"EEM Kolsteren","year":"2022","unstructured":"Kolsteren EEM, Deuning-Smit E, Chu AK, van der Hoeven YCW, Prins JB, van der Graaf WTA, et al. Psychosocial aspects of living long term with advanced cancer and ongoing systemic treatment: a scoping review. Cancers. 2022;14(16):3889.","journal-title":"Cancers"},{"key":"1698_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/00302228221121493","author":"CYS Lim","year":"2022","unstructured":"Lim CYS, Laidsaar-Powell RC, Young JM, Solomon M, Steffens D, Blinman P, et al. Fear of cancer progression and death anxiety in survivors of advanced colorectal cancer: a qualitative study exploring coping strategies and quality of Life. Omega (Westport). 2022. https:\/\/doi.org\/10.1177\/00302228221121493.","journal-title":"Omega (Westport)"},{"issue":"4","key":"1698_CR23","first-page":"1187","volume":"27","author":"J van Roij","year":"2019","unstructured":"van Roij J, Brom L, Youssef-El Soud M, van de Poll-Franse L, Raijmakers NJH. Social consequences of advanced cancer in patients and their informal caregivers: a qualitative study. Support Care Cancer. 2019;27(4):1187\u201395.","journal-title":"Support Care Cancer"},{"key":"1698_CR24","doi-asserted-by":"publisher","first-page":"103728","DOI":"10.1016\/j.critrevonc.2022.103728","volume":"176","author":"NH Hart","year":"2022","unstructured":"Hart NH, Crawford-Williams F, Crichton M, Yee J, Smith TJ, Koczwara B, et al. Unmet supportive care needs of people with advanced cancer and their caregivers: a systematic scoping review. Crit Rev Oncol Hematol. 2022;176:103728.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1698_CR25","doi-asserted-by":"publisher","first-page":"827947","DOI":"10.3389\/fpsyg.2022.827947","volume":"13","author":"M Hasdenteufel","year":"2022","unstructured":"Hasdenteufel M, Quintard B. Dyadic experiences and psychosocial management of couples facing advanced cancer: a systematic review of the literature. Front Psychol. 2022;13:827947.","journal-title":"Front Psychol"},{"issue":"12","key":"1698_CR26","first-page":"721","volume":"31","author":"VWG Burgers","year":"2023","unstructured":"Burgers VWG, Reuvers MJP, Taphoorn MJB, Kok M, de Langen AJ, van den Bent MJ, et al. A qualitative study on the healthcare experiences of adolescents and young adults (AYA) with an uncertain or poor cancer prognosis. Support Care Cancer. 2023;31(12):721.","journal-title":"Support Care Cancer"},{"issue":"4","key":"1698_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jnci\/djab223","volume":"114","author":"MA Mollica","year":"2022","unstructured":"Mollica MA, Smith AW, Tonorezos E, Castro K, Filipski KK, Guida J, et al. Survivorship for individuals living with advanced and metastatic cancers: National Cancer Institute meeting report. J Natl Cancer Inst. 2022;114(4):489\u201395.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1698_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"2","key":"1698_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"24","key":"1698_CR30","first-page":"56","volume":"177","author":"FB Scanxiety","year":"2011","unstructured":"Scanxiety FB. Fear of a postcancer ritual. Time. 2011;177(24):56.","journal-title":"Time"},{"issue":"1","key":"1698_CR31","first-page":"511","volume":"30","author":"KT Bui","year":"2021","unstructured":"Bui KT, Kiely BE, Dhillon HM, Brown C, Xu K, Shafiei M, Blinman P. Prevalence and severity of scanxiety in people with advanced cancers: a multicentre survey. Support Care Cancer. 2021;30(1):511\u20139.","journal-title":"Support Care Cancer"},{"issue":"5","key":"1698_CR32","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3390\/cancers15051381","volume":"15","author":"HM Derry-Vick","year":"2023","unstructured":"Derry-Vick HM, Heathcote LC, Glesby N, Stribling J, Luebke M, Epstein AS, Prigerson HG. Scanxiety among adults with cancer: a scoping review to guide research and interventions. Cancers. 2023;15(5):1381.","journal-title":"Cancers"},{"issue":"9","key":"1698_CR33","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1002\/cam4.3889","volume":"10","author":"JAE Custers","year":"2021","unstructured":"Custers JAE, Davis L, Messiou C, Prins JB, van der Graaf WTA. The patient perspective in the era of personalized medicine: what about scanxiety? Cancer Med. 2021;10(9):2943\u20135.","journal-title":"Cancer Med"},{"key":"1698_CR34","doi-asserted-by":"publisher","first-page":"e067572","DOI":"10.1136\/bmj-2021-067572","volume":"376","author":"JJ Sanders","year":"2022","unstructured":"Sanders JJ, Manson L, Constien D, Downar J. Discussing prognosis and what matters most for people with serious illness. BMJ. 2022;376:e067572.","journal-title":"BMJ"},{"issue":"9","key":"1698_CR35","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1016\/S1470-2045(17)30582-X","volume":"18","author":"JAC Rietjens","year":"2017","unstructured":"Rietjens JAC, Sudore RL, Connolly M, van Delden JJ, Drickamer MA, Droger M, et al. Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care. Lancet Oncol. 2017;18(9):e543\u201351.","journal-title":"Lancet Oncol"},{"issue":"14","key":"1698_CR36","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1001\/jama.300.14.1665","volume":"300","author":"AA Wright","year":"2008","unstructured":"Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, Jackson VA, Block SD, Maciejewski PK, Prigerson HG. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14):1665\u201373.","journal-title":"JAMA"},{"issue":"2","key":"1698_CR37","first-page":"227","volume":"8","author":"Y Cai","year":"2021","unstructured":"Cai Y, Simons A, Toland S, Zhang J, Zheng K. Informal caregivers\u2019 quality of life and management strategies following the transformation of their cancer caregiving role: a qualitative systematic review. Int J Nurs Sci. 2021;8(2):227\u201336.","journal-title":"Int J Nurs Sci"},{"issue":"6","key":"1698_CR38","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/0193945914525280","volume":"37","author":"MC Chen","year":"2015","unstructured":"Chen MC, Chen KM, Chu TP. Caregiver burden, health status, and learned resourcefulness of older caregivers. West J Nurs Res. 2015;37(6):767\u201380.","journal-title":"West J Nurs Res"},{"issue":"12","key":"1698_CR39","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/pon.6233","volume":"32","author":"L Ham","year":"2023","unstructured":"Ham L, Fransen HP, Raijmakers NJH, van den Beuken-van Everdingen MHJ, van den Borne B, Creemers GJ, et al. Trajectories of emotional functioning and experienced care of relatives in the last year of life of patients with advanced cancer: a longitudinal analysis of the eQuiPe study. Psychooncology. 2023;32(12):1858\u201366.","journal-title":"Psychooncology"},{"issue":"5","key":"1698_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jpainsymman.2023.01.012","volume":"65","author":"NCA van der Velden","year":"2023","unstructured":"van der Velden NCA, Smets EMA, Hagedoorn M, Applebaum AJ, Onwuteaka-Philipsen BD, van Laarhoven HWM, Henselmans I. Patient-caregiver dyads\u2019 prognostic information preferences and perceptions in advanced cancer. J Pain Symptom Manag. 2023;65(5):442-455.e2.","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"1698_CR41","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00345-023-04325-y","volume":"41","author":"TJ Bugaj","year":"2023","unstructured":"Bugaj TJ, Maatouk I, Hanslmeier T, Zschabitz S, Huber J, Flock C, et al. Couples coping with advanced prostate cancer: an explorative study on decision-making preferences, self-efficacy and fear of progression. World J Urol. 2023;41(4):1041\u20136.","journal-title":"World J Urol"},{"key":"1698_CR42","doi-asserted-by":"publisher","first-page":"102523","DOI":"10.1016\/j.ejon.2024.102523","volume":"69","author":"M Franklin","year":"2024","unstructured":"Franklin M, Lewis S, Townsend J, Warren M, Boyle F, Smith AL. Making the unbearable, bearable: qualitative examination of patient, family and nurses\u2019 perspectives on the role and value of specialist metastatic breast care nurses. Eur J Oncol Nurs. 2024;69:102523.","journal-title":"Eur J Oncol Nurs"},{"issue":"17","key":"1698_CR43","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3390\/healthcare11172434","volume":"11","author":"A Bednarek","year":"2023","unstructured":"Bednarek A, Klepacz R, Bodys-Cupak IE. The role of the nurse in the care and management of patients with rheumatic diseases arising from the current EULAR recommendations: a literature review. Healthcare (Basel). 2023;11(17):2434.","journal-title":"Healthcare (Basel)"},{"issue":"4","key":"1698_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/13561820.2010.539305","volume":"25","author":"M Van Soeren","year":"2011","unstructured":"Van Soeren M, Hurlock-Chorostecki C, Reeves S. The role of nurse practitioners in hospital settings: implications for interprofessional practice. J Interprof Care. 2011;25(4):245\u201351.","journal-title":"J Interprof Care"},{"key":"1698_CR45","doi-asserted-by":"publisher","first-page":"151370","DOI":"10.1016\/j.apnr.2020.151370","volume":"56","author":"T Alotaibi","year":"2020","unstructured":"Alotaibi T, Al Anizi CA. The impact of advanced nurse practitioner (ANP) role on adult patients with cancer: a quantitative systematic review. Appl Nurs Res. 2020;56:151370.","journal-title":"Appl Nurs Res"},{"issue":"10","key":"1698_CR46","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1177\/0269216313499961","volume":"27","author":"G Rodin","year":"2013","unstructured":"Rodin G. Research on psychological and social factors in palliative care: an invited commentary. Palliat Med. 2013;27(10):925\u201331.","journal-title":"Palliat Med"},{"key":"1698_CR47","doi-asserted-by":"publisher","first-page":"100051","DOI":"10.1016\/j.glmedi.2024.100051","volume":"2","author":"SK Ahmed","year":"2024","unstructured":"Ahmed SK. The pillars of trustworthiness in qualitative research. J Med Surg Public Health. 2024;2:100051.","journal-title":"J Med Surg Public Health"},{"key":"1698_CR48","doi-asserted-by":"publisher","first-page":"100455","DOI":"10.1016\/j.jcpo.2023.100455","volume":"39","author":"A Gedik","year":"2024","unstructured":"Gedik A, van Meerten E, Reuvers MJP, Husson O, van der Graaf WTA. The views of cancer patients of Turkish, Moroccan, Surinamese, and Dutch-Caribbean descent on diagnosis, treatment and prognosis: a systematic literature review. J Cancer Policy. 2024;39:100455.","journal-title":"J Cancer Policy"},{"issue":"1","key":"1698_CR49","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12874-019-0867-9","volume":"19","author":"M Krouwel","year":"2019","unstructured":"Krouwel M, Jolly K, Greenfield S. Comparing Skype (video calling) and in-person qualitative interview modes in a study of people with irritable bowel syndrome - an exploratory comparative analysis. BMC Med Res Methodol. 2019;19(1):219.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"1698_CR50","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/0269216321989571","volume":"35","author":"G Foley","year":"2021","unstructured":"Foley G. Video-based online interviews for palliative care research: a new normal in COVID-19? Palliat Med. 2021;35(3):625\u20136.","journal-title":"Palliat Med"},{"key":"1698_CR51","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s11764-021-01024-8","volume":"15","author":"J Lai-Kwon","year":"2021","unstructured":"Lai-Kwon J, Heynemann S, Flore J, Dhillon H, Duffy M, Burke J, et al. Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapy. J Cancer Surviv. 2021;15:392\u20137.","journal-title":"J Cancer Surviv"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01698-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-024-01698-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01698-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:04:31Z","timestamp":1777989871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-024-01698-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1698"],"URL":"https:\/\/doi.org\/10.1007\/s11764-024-01698-w","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed by the local medical ethical committee and judged to be exempt from medical ethical review (CMO Arnhem-Nijmegen 2020\u201361613). The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided their written informed consent, prior to enrolment in this interview study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}